Posted inGenetics
New CRISPRs to Probe the Human Noncoding Genome with Neville Sanjana
In a keynote talk during GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11,…
Posted inGenetics
Stuttering’s Genomic Signature Identifies 57 Loci and Links to Autism, Depression, and Musical Rhythm
Stuttering affects many people; indeed, the American Speech-Language-Hearing Association (ASHA) estimates that stuttering affects approximately 1% of the world’s population…
Posted inGenetics
Sarepta to Resume Shipping DMD Gene Therapy to Ambulant Patients
Sarepta Therapeutics said it will resume shipments of its gene therapy Elevidys® (delandistrogene moxeparvovec-rokl) “imminently” to ambulant patients with Duchenne…
Posted inGenetics
GeneAgent Reduces AI Hallucinations in Gene Function Prediction
Gene-set analysis seeks to identify the biological mechanisms underlying groups of genes with shared functions. Large language models (LLMs) have…
Posted inGenetics
TF Binding Mapped via DynaTag in Single Cells, Low-Input Samples
Mapping transcription factor (TF) binding sites across the genome is key to understanding how cells control gene expression, yet pinpointing…
Posted inGenetics
Antimicrobial Resistance Strategies May Be Informed by Bacteria’s Kiwa Phage Defense System
Researchers at the University of Southampton have used advanced imaging techniques to uncover how bacteria use a mechanism called Kiwa…
Posted inGenetics
First Arab Human Pangenome Sequenced
Scientists published the first Arab human pangenome in Nature Communications, which was largely accomplished by using PacBio’s HiFi long-read sequencing.…
Posted inGenetics
Mass Administration of Ivermectin Slows Malaria Transmission in Kenya
Despite the headlines a few years ago, ivermectin is not an effective treatment for COVID-19. However, the broad-spectrum antiparasitic drug…
Posted inGenetics
Mitophagy Mechanism Unlocks Therapy Path for Parkinson’s Disease
Autophagy is a natural, conserved process where cells degrade and recycle their own components, including damaged proteins and organelles. This…
Posted inGenetics
StockWatch: Abivax Shares Leap on Phase III Ulcerative Colitis Data, $747.5M Offering
Abivax CEO Marc de Garidel A day after surpassing its own expectations with dazzling Phase III data for its lead…